Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.25
Bid: 19.00
Ask: 19.50
Change: 0.00 (0.00%)
Spread: 0.50 (2.632%)
Open: 19.25
High: 19.25
Low: 18.75
Prev. Close: 19.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Franchise Brands trading in line; Tribe secures loan

Wed, 25th Oct 2023 17:28

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

First Tin PLC - London-based tin development company, fotheycused on advanced, low-capital expenditure projects in Germany and Australia - Updates on the definitive feasibility study at its Taronga tin project in Australia. The project is owned by First Tin's 100% owned Australian subsidiary, Taronga Mines Pty Ltd. Explains the resource is significantly larger than estimated due to a combination of, a lower cut-off grade and newly identified mineralisation to the south-west. As a result, a higher throughput has been decided on for the DFS, resulting in economies of scale. Expects completion of the DFS in the first quarter of 2024. Chief Executive Thomas Buenger says: "We are pleased with the DFS outcomes at our flagship Taronga tin deposit, which have validated our assumptions held prior to the study. The simple mineralogy and subsequent mineral processing characteristics, combined with the low strip ratio and open pit mineability of the deposit, make it one of the most straightforward hard rock tin deposits in the world."

----------

Molecular Energies PLC - oil, gas and alternative energy company with an exploration asset in Paraguay - Says final on-site commissioning of the drilling rig in Paraguay is taking place. Understands from the drilling company that the repaired blow out preventer has passed its operational tests in Brazil, from where it is due to be shipped, and is currently expected to be on site at or around the end of the second week of November. Explains the BOP is a critical safety component of the drilling rig and Molecular will not authorise any drilling activities unless it receives certification. Points out the well, if successful, will potentially unlock a complex of prospects, estimated to contain in aggregate over 260 million of barrels of oil. The potential of the prize makes this exploration well compelling, company says. Further, notes the cash flow from the recent sale of the Argentine hydrocarbon assets will commence during 2024, providing an uplift to the company's financial position. Thereafter, and irrespective of the outcome of the Paraguay exploration programme, intends to focus resources on originating and developing alternative energy projects of scale with attractive long-term returns. Also plans to pursue interests in sustainable aviation fuels.

----------

Power Metal Resources PLC - metals exploration company focused on North America, Africa, and Australia - Provides business update following end of financial year to September 30. Chief Executive Sean Wade says he expects "various news updates in the near term, informing shareholders of the outcomes of current exploration programmes, the launch of new exploration activities and the results of our corporate activities seeking value crystallisation and streamlining of the company." Says short term objectives are to complete transactions with third parties looking to acquire business interests, and enter into joint ventures; to focus on major metal discoveries from its retained in-house portfolio; to expand the ownership of Power Metal shares into new investor groups; identify new territories for future business opportunities, including notably Saudi Arabia and Oman; and focus on value growth in the Power Metal portfolio through exploration and value crystallisation, so as to materially increase the company's market valuation.

----------

Tribe Technology PLC - Belfast-based developer and manufacturer of autonomous mining equipment - Enters into a GBP3.0 million secured term loan facility agreement with BPC UK Lending DAC. Explains funds will refinance the legacy debt arrangements and further progress the previously outlined execution strategy. Following drawdown of the facility, the company will have repaid its entire GBP0.52 million existing debt facility with Growth Finance Fund LP inclusive of accrued interest and fees. The facility is for a five-year term and bears interest at 13% per year.

----------

Franchise Brands PLC - Manchester-based owner of ChipsAway, Willow Pumps and Metro Rod brands - Provides trading update for the three months to September 30. Reports the business to business units, are all trading at record levels despite some softening in demand over the summer period. Consequently, the third quarter was a little softer than in the first half, but there was a modest increase in activity at the start of the fourth quarter. Says Pirtek is integrating well and has met expectations at the time of its acquisition. Plans to accelerate the integration process. States the business to consumer division continues to operate in a challenging environment, although profitability is being maintained in line with expectations. Group debt has reduced to GBP76.0 million as at September 30 from GBP79.1 million at June 30, and the company is trading comfortably within key banking covenants. Expects adjusted earnings before interest, tax and amortisation for the year ending December 2023 to be in line with current consensus market expectations.

----------

Sound Energy PLC - London-based, Morocco-focused upstream gas company - Confirms the extension of both the Office National de l'Electricite et de l'Eau Potable gas sales agreement and the Attijariwafa bank funding offer until December 31. Graham Lyon executive chair says: "Various elements within the GSA are being amended to meet the debt funders criteria and to meet international standards. As such, Sound Energy, ONHYM, ONEE and Attijariwafa bank are engaged under the auspices of the Ministry of Energy to conclude a revised GSA by year end."

----------

Angle PLC - Surrey, England-based medical diagnostics company - Publishes study using the Parsortix system that sheds new light on the phenotypic characteristics of circulating tumour cells in head and neck squamous cell carcinoma. The study demonstrates the feasibility of using mass cytometry for the comprehensive characterisation of CTCs captured by the Parsortix system in HNSCC patients. This enables simultaneous analysis of multiple proteins on and within individual CTCs, providing an understanding of their phenotypic status and diversity. HNSCC is an aggressive, genetically complex, and difficult to treat group of cancers with limited options for early detection and monitoring. Chief Scientific Officer, Karen Miller, says: "The Parsortix system allows for the unbiased isolation and harvest of CTCs and as such, can enable the evaluation of phenotypically diverse CTCs in a patient's blood. This could lead to future improvements in clinical decision making."

----------

Angus Energy PLC - UK-focused oil and gas development company - Ahead of general meeting, clarifies that the agreement with Kemexon, originally announced March 28, requires that any conversion of the loan into equity was conditional on a conversion being mutually agreed by Kemexon and the company. Explains that due to the company's financial position, the company was only able to agree conversion of the loan at a price per share of 0.66 pence. Recognises that this is below the initially intended conversion price of 1p. But, due to the drop in share price, feels it was a good result to have discharged a loan at market price and therefore at no discount to the prevailing share price.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
22 Jul 2019 12:53

Angle's Parsortix Used For Analysis Of Circulating Tumor Cells

(Alliance News) - Angle PLC on Monday said one of its leading customers, the Disseminated Cancer Cell Network, has published new results of work done to develop a "robust, reliable and for of

Read more
25 Jun 2019 08:16

Angle looks to strengthen balance sheet and extend runway via placement

(Sharecast News) - Liquid biopsy company Angle will look to raise up £18m at 61.5p per ordinary share through finnCap and WG Partners in order to strengthen its balance sheet and enable the development of key products.

Read more
21 Jun 2019 15:26

Angle upbeat on recent cancer research results

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the University Medical Centre Hamburg-Eppendorf (UKE) cancer centre has published results of work demonstrating that its 'Parsortix' system can be used as a liquid biopsy to investigate programmed death-ligand 1 (PD-L1) status in non small cell lung cancer (NSCLC) patients.

Read more
21 Jun 2019 12:56

Angle's Parsortix Successfully Investigates Immunotherapy Target

(Alliance News) - Angle PLC on Friday said its Parsortix system has been successfully used as a liquid biopsy to investigate an immunotherapy target in lung cancer.Shares in Angle were up a

Read more
5 Jun 2019 13:04

Angle's Parsortix And HyCEAD Ziplex Systems Identify Cancer In Study

LONDON (Alliance News) - Angle PLC on Wednesday announced positive results from a study evaluating the ability of its Parsortix and HyCEAD Ziplex platforms to test for ovarian cancer.The to

Read more
31 May 2019 09:53

Angle reveals positive results from latest Parsortix study

(Sharecast News) - Liquid biopsy company Angle announced positive results from its 'Parsortix' FDA clinical study for metastatic breast cancer on Friday.

Read more
26 Apr 2019 12:48

Angle's Parsortix system used in more groundbreaking research

(Sharecast News) - Liquid biopsy company Angle announced on Friday that its 'Parsortix' system has been utilised in further groundbreaking new cancer research, demonstrating the role of myeloid-derived suppressor cells (MDSCs) as part of large circulating tumor cell (CTC) clusters, which are 50x more likely to generate metastasis than single CTCs, for the first time.

Read more
26 Apr 2019 12:29

Angle's Parsortix System Used In Further "Groundbreaking" Research

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said its Parsortix system has been used in "groundbreaking" cancer research.The research showed the first the time

Read more
18 Apr 2019 11:35

US Cancer Centre Uses Angle's Parsortix System For Assessments

LONDON (Alliance News) - Angle PLC on Thursday said its ParsortixTM system was used by the University of Texas MD Anderson Cancer Center to develop a new technique for assessing the metastatic of

Read more
12 Apr 2019 15:25

Angle's Parsortix to be used in new Greece study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that a leading customer has established a multi-centre study to investigate biomarkers on circulating tumor cells (CTCs), using its 'Parsortix' system, which could give advance warning of relapse in non small cell lung cancer (NSCLC).

Read more
12 Apr 2019 11:59

University Of Athens Cancer Study To Use Angle's Parsortix System

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said a "leading" customer has set up a multi-centre study using its Parsortix system.The study is being carried out

Read more
7 Mar 2019 13:09

Angle Enrols All 400 Patients In US Breast Cancer Study For Parsortix

LONDON (Alliance News) - Angle PLC on Thursday said it has completed enrolment for a US study of its Parsortix biopsy technology in metastatic breast cancer.All of the 400 subjects required

Read more
7 Mar 2019 09:35

Angle completes enrolment in Parsortix breast cancer study

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that enrolment for its 'Parsortix' FDA clinical study for metastatic breast cancer was now complete.

Read more
28 Feb 2019 13:30

Angle Enrolls First Patients In Ovarian Cancer Study

LONDON (Alliance News) - Angle PLC on Thursday said it has enrolled the first patients in an ovarian cancer verification study, after receiving ethics approval.The study will be divided a a

Read more
25 Feb 2019 10:51

Angle client demonstrates new use for 'Parsortix' system

(Sharecast News) - Liquid biopsy company Angle said on Monday that one of its leading customers, the Disseminated Cancer Cell Network (DCCNet) in Duesseldorf, has published new results in a peer-reviewed journal of work done to harvest circulating tumor cells (CTCs) from diagnostic leukapheresis (DLA) samples.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.